Mario Corbellino

InstitutionIII Division of Infectious Diseases
AddressMilano
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 5 publications in May 2020
    All Publications
    Bar chart showing 63 publications over 16 distinct years, with a maximum of 12 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cattaneo D, Corbellino M, Cozzi V, Fusi M, Gervasoni C. Comment on "Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6". Clin Pharmacokinet. 2021 06; 60(6):829-831. PMID: 33864625.
      Citations: 1     Fields:    Translation:Humans
    2. Chiveri L, Verrengia E, Muscia F, Nuzzaco G, Raimondi E, Vecchio E, Bompane D, Mazzone A, Fociani P, Corbellino M, Prelle A. Limbic encephalitis in a COVID-19 patient? J Neurovirol. 2021 06; 27(3):498-500. PMID: 33825173.
      Citations: 1     Fields:    Translation:Humans
    3. Schiuma M, Pezzati L, Ballone E, Borghi B, Osio M, Mattavelli D, Galimberti L, Corbellino M, Mileto D, Zanchetta N, Antinori S. Case Report: A Fatal Case of West Nile Virus Meningoencephalomyelitis in a Woman with Systemic Lupus Erythematosus Initially Misdiagnosed as SARS-CoV-2 Infection. Am J Trop Med Hyg. 2021 Mar 29; 104(5):1716-1718. PMID: 33782207.
      Citations:    Fields:    
    4. Milazzo L, Lai A, Pezzati L, Oreni L, Bergna A, Conti F, Meroni C, Minisci D, Galli M, Corbellino M, Antinori S, Ridolfo AL. Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy. Occup Environ Med. 2021 Feb 04. PMID: 33542096.
      Citations: 5     Fields:    
    5. Cattaneo D, Corbellino M, Gervasoni C. Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts. Eur J Clin Pharmacol. 2021 05; 77(5):791-792. PMID: 33241457.
      Citations: 1     Fields:    Translation:Humans
    6. Sims JT, Krishnan V, Chang CY, Engle SM, Casalini G, Rodgers GH, Bivi N, Nickoloff BJ, Konrad RJ, de Bono S, Higgs RE, Benschop RJ, Ottaviani S, Cardoso A, Nirula A, Corbellino M, Stebbing J. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J Allergy Clin Immunol. 2021 01; 147(1):107-111. PMID: 32920092.
      Citations: 33     Fields:    Translation:Humans
    7. Baldelli S, Corbellino M, Clementi E, Cattaneo D, Gervasoni C. Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? J Antimicrob Chemother. 2020 09 01; 75(9):2704-2706. PMID: 32407513.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    8. Stebbing J, Krishnan V, de Bono S, Ottaviani S, Casalini G, Richardson PJ, Monteil V, Lauschke VM, Mirazimi A, Youhanna S, Tan YJ, Baldanti F, Sarasini A, Terres JAR, Nickoloff BJ, Higgs RE, Rocha G, Byers NL, Schlichting DE, Nirula A, Cardoso A, Corbellino M. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med. 2020 08 07; 12(8):e12697. PMID: 32473600.
      Citations: 69     Fields:    Translation:HumansCellsPHPublic Health
    9. Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, Rech R, Colombo R, Antinori S, Corbellino M, Galli M, Catena E, Tosoni A, Gianatti A, Nebuloni M. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020 10; 20(10):1135-1140. PMID: 32526193.
      Citations: 419     Fields:    Translation:HumansCellsPHPublic Health
    10. Morena V, Milazzo L, Oreni L, Bestetti G, Fossali T, Bassoli C, Torre A, Cossu MV, Minari C, Ballone E, Perotti A, Mileto D, Niero F, Merli S, Foschi A, Vimercati S, Rizzardini G, Sollima S, Bradanini L, Galimberti L, Colombo R, Micheli V, Negri C, Ridolfo AL, Meroni L, Galli M, Antinori S, Corbellino M. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020 06; 76:36-42. PMID: 32448770.
      Citations: 84     Fields:    Translation:HumansCellsPHPublic Health
    11. Antinori S, Cossu MV, Ridolfo AL, Rech R, Bonazzetti C, Pagani G, Gubertini G, Coen M, Magni C, Castelli A, Borghi B, Colombo R, Giorgi R, Angeli E, Mileto D, Milazzo L, Vimercati S, Pellicciotta M, Corbellino M, Torre A, Rusconi S, Oreni L, Gismondo MR, Giacomelli A, Meroni L, Rizzardini G, Galli M. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899. PMID: 32407959.
      Citations: 59     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    12. Cattaneo D, Cattaneo D, Gervasoni C, Corbellino M, Galli M, Riva A, Gervasoni C, Clementi E, Clementi E. Does lopinavir really inhibit SARS-CoV-2? Pharmacol Res. 2020 08; 158:104898. PMID: 32438034.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    13. Capaccio P, Pignataro L, Corbellino M, Popescu-Dutruit S, Torretta S. Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection? Otolaryngol Head Neck Surg. 2020 07; 163(1):182-183. PMID: 32369434.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    14. Richardson PJ, Ottaviani S, Prelle A, Stebbing J, Casalini G, Corbellino M. CNS penetration of potential anti-COVID-19 drugs. J Neurol. 2020 Jul; 267(7):1880-1882. PMID: 32361836.
      Citations: 11     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    15. Richardson PJ, Corbellino M, Stebbing J. Baricitinib for COVID-19: a suitable treatment? - Authors' reply. Lancet Infect Dis. 2020 09; 20(9):1013-1014. PMID: 32251639.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
    Corbellino's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (122)
    Explore
    _
    Co-Authors (112)
    Explore
    _
    Similar People (60)
    Explore
    _